{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:29:53Z","timestamp":1795080593264,"version":"4.10.2"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Surgeon"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.surge.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:49:51Z","timestamp":1770900591000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Validation and clinical utility of predictive nomograms for sentinel node positivity in cutaneous malignant melanoma in Ireland"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-6867","authenticated-orcid":false,"given":"N.","family":"Christodoulides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Quirke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7111-8853","authenticated-orcid":false,"given":"A.","family":"Ghinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2237-9245","authenticated-orcid":false,"given":"Q.","family":"Jeantet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.surge.2026.02.003_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17040707","article-title":"Clinical approaches for the management of skin cancer: a review of current progress in diagnosis, treatment, and prognosis for patients with melanoma","volume":"17","author":"Connor","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"158","key":"10.1016\/j.surge.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"5","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.surge.2026.02.003_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040822","article-title":"The current state of treatment and future directions in cutaneous malignant melanoma","volume":"10","author":"Ernst","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.surge.2026.02.003_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99950-1","article-title":"Prognostic factors and population-based analysis of melanoma with sentinel lymph node biopsy","volume":"11","author":"Wu","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.surge.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surge.2026.02.003_bib6","series-title":"National Comprehensive Cancer Network (NCCN) Guidelines 2025","year":"2025"},{"issue":"7","key":"10.1016\/j.surge.2026.02.003_bib7","first-page":"402","article-title":"Cutaneous melanoma and sentinel lymph node biopsy; an epidemiology study of population level data","volume":"114","author":"Scanlon","year":"2021","journal-title":"Ir Med J"},{"key":"10.1016\/j.surge.2026.02.003_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/jso.70035","article-title":"Validation of a clinicopathologic and gene expression model for predicting sentinel node metastasis in melanoma: a multicenter Danish cohort study","author":"Weitemeyer","year":"2025","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.surge.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamasurg.2023.6904","article-title":"Population-based validation of the MIA and MSKCC tools for predicting sentinel lymph node status","volume":"159","author":"Olofsson Bagge","year":"2024","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.surge.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1245\/ASO.2005.05.016","article-title":"A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American joint committee on cancer staging system","volume":"12","author":"Wong","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"24","key":"10.1016\/j.surge.2026.02.003_bib11","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.19.02362","article-title":"Improved risk prediction calculator for sentinel node positivity in patients with melanoma: the melanoma institute Australia nomogram","volume":"38","author":"Lo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surge.2026.02.003_bib12","author":"LfQ"},{"issue":"2","key":"10.1016\/j.surge.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjd.19895","article-title":"Predicting sentinel node positivity in patients with melanoma: external validation of a risk\u2010prediction calculator (the Melanoma Institute Australia nomogram) using a large European population\u2010based patient cohort","volume":"185","author":"El Sharouni","year":"2021","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.surge.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamadermatol.2025.0318","article-title":"Global applicability of a risk prediction tool for Sentinel Node positivity in patients with primary cutaneous melanoma","volume":"161","author":"Lo","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.surge.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11845-014-1166-4","article-title":"Validation of a nomogram predicting sentinel lyph node status in melanoma in an Irish population","volume":"184","author":"Woods","year":"2014","journal-title":"Ir J Med Sci"},{"issue":"1","key":"10.1016\/j.surge.2026.02.003_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagnostic and Prognostic Research"},{"issue":"8","key":"10.1016\/j.surge.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.surge.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.surge.2026.02.003_bib19","series-title":"SEER cancer stat facts: melanoma of the skin","year":"2025"},{"issue":"5","key":"10.1016\/j.surge.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1503\/cjs.016023","article-title":"False-negative sentinel lymph node biopsy for melanoma: a single-surgeon experience","volume":"67","author":"Downey","year":"2024","journal-title":"Can J Surg"},{"issue":"7","key":"10.1016\/j.surge.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/jso.27231","article-title":"Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?","volume":"127","author":"Hosein","year":"2023","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.surge.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (\u2a7d1 mm) than from thick melanomas (>4 mm) in Queensland, Australia","volume":"135","author":"Whiteman","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.surge.2026.02.003_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","article-title":"Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013","volume":"76","author":"Landow","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.surge.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/jid.2009.328","article-title":"Melanoma thickness trends in the United States, 1988\u20132006","volume":"130","author":"Criscione","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"10336","key":"10.1016\/j.surge.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0140-6736(22)00562-1","article-title":"Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial","volume":"399","author":"Luke","year":"2022","journal-title":"Lancet"}],"container-title":["The Surgeon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X26000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X26000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:04:58Z","timestamp":1771344298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1479666X26000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"alternative-id":["S1479666X26000120"],"URL":"https:\/\/doi.org\/10.1016\/j.surge.2026.02.003","relation":{},"ISSN":["1479-666X"],"issn-type":[{"value":"1479-666X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation and clinical utility of predictive nomograms for sentinel node positivity in cutaneous malignant melanoma in Ireland","name":"articletitle","label":"Article Title"},{"value":"The Surgeon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surge.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}